Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell
• Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Earnings Scheduled For August 9, 2023
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
‘I Think It’s Going Nowhere:’ Jim Cramer On Major Telecom Company
On CNBC’s "Mad Money Lightning Round," Jim Cramer said U-Haul Holding Company (NYSE: UHAL) is a "very inexpensive stock…I think it is unheralded and is going higher, even though it’s
Benzinga’s Top Ratings Upgrades, Downgrades For June 30, 2023
Upgrades For Bright Health Group Inc (NYSE:BHG), Nephron Research upgraded the previous rating of Hold to Buy. In…
Will Chart Analysts Notice Bad Omen on U-Haul Holding’s Chart
If history is any guide, there may be trouble ahead for shares of U-Haul Holding (NYSE:UHAL). A so-called…
3 REITs Hit With New Downgrades To Start The Week
Wall Street analysts wield a lot of influence. A favorable or unfavorable mention of a stock by a well-known analyst or brokerage can move a stock up or down by several percentage points overnight. In the case of a downgrade or severe price target slash, it can take weeks or longer for a stock to recover.
U-Haul Holding’s Ex-Dividend Date Is Friday, Here’s What You Need To Know
Thursday marks the last chance for investors to receive the next dividend payout from U-Haul Holding (NYSE:UHAL). What’s…
U-Haul Investing in Bowling Green, To Build New Store, Add Jobs By 2025
U-Haul® will soon showcase a new retail, moving and self-storage center in Bowling Green thanks to the recent land acquisition of 5.15 acres on Nashville Road, just southwest of William H. Natcher Parkway.U-Haul
Why Is U-Haul Stock Trading Down Wednesday?
U-Haul Holding Company (NYSE: UHAL) shares are moving lower Wednesday on the heels of a disappointing earnings report.
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.